These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 32184441)
1. Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation. Patsoukis N; Duke-Cohan JS; Chaudhri A; Aksoylar HI; Wang Q; Council A; Berg A; Freeman GJ; Boussiotis VA Commun Biol; 2020 Mar; 3(1):128. PubMed ID: 32184441 [TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of SHP2 activation by PD-1 stimulation. Marasco M; Berteotti A; Weyershaeuser J; Thorausch N; Sikorska J; Krausze J; Brandt HJ; Kirkpatrick J; Rios P; Schamel WW; Köhn M; Carlomagno T Sci Adv; 2020 Jan; 6(5):eaay4458. PubMed ID: 32064351 [TBL] [Abstract][Full Text] [Related]
3. Probing the Immunoreceptor Tyrosine-Based Inhibition Motif Interaction Protein Partners with Proteomics. Gao Y; Xing S; Hu L Molecules; 2024 Apr; 29(9):. PubMed ID: 38731468 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells. Bardhan K; Aksoylar HI; Le Bourgeois T; Strauss L; Weaver JD; Delcuze B; Charest A; Patsoukis N; Boussiotis VA Sci Rep; 2019 Nov; 9(1):17252. PubMed ID: 31754127 [TBL] [Abstract][Full Text] [Related]
5. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. Chemnitz JM; Parry RV; Nichols KE; June CH; Riley JL J Immunol; 2004 Jul; 173(2):945-54. PubMed ID: 15240681 [TBL] [Abstract][Full Text] [Related]
6. Marasco M; Kirkpatrick JP; Carlomagno T Biomol NMR Assign; 2020 Oct; 14(2):179-188. PubMed ID: 32236803 [TBL] [Abstract][Full Text] [Related]
7. Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors. Xu X; Masubuchi T; Cai Q; Zhao Y; Hui E Elife; 2021 Nov; 10():. PubMed ID: 34734802 [TBL] [Abstract][Full Text] [Related]
8. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B. Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385 [TBL] [Abstract][Full Text] [Related]
9. A novel phosphotyrosine motif with a critical amino acid at position -2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1. Burshtyn DN; Yang W; Yi T; Long EO J Biol Chem; 1997 May; 272(20):13066-72. PubMed ID: 9148918 [TBL] [Abstract][Full Text] [Related]
10. An investigation of hierachical protein recruitment to the inhibitory platelet receptor, G6B-b. Coxon CH; Sadler AJ; Huo J; Campbell RD PLoS One; 2012; 7(11):e49543. PubMed ID: 23185356 [TBL] [Abstract][Full Text] [Related]
11. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. Shlapatska LM; Mikhalap SV; Berdova AG; Zelensky OM; Yun TJ; Nichols KE; Clark EA; Sidorenko SP J Immunol; 2001 May; 166(9):5480-7. PubMed ID: 11313386 [TBL] [Abstract][Full Text] [Related]
12. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Eissmann P; Beauchamp L; Wooters J; Tilton JC; Long EO; Watzl C Blood; 2005 Jun; 105(12):4722-9. PubMed ID: 15713798 [TBL] [Abstract][Full Text] [Related]
13. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions. Nakamura K; Brauweiler A; Cambier JC J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804 [TBL] [Abstract][Full Text] [Related]
14. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells. Yusa S; Catina TL; Campbell KS J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457 [TBL] [Abstract][Full Text] [Related]
15. Conformational Changes in the Cytoplasmic Region of KIR3DL1 upon Interaction with SHP-2. Cheng H; Schwell V; Curtis BR; Fazlieva R; Roder H; Campbell KS Structure; 2019 Apr; 27(4):639-650.e2. PubMed ID: 30773397 [TBL] [Abstract][Full Text] [Related]
16. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646 [TBL] [Abstract][Full Text] [Related]